GLP-1 Receptor Agonists Post-Bariatric Surgery (GRABS) Feasibility Trial
Status:
Not yet recruiting
Trial end date:
2027-12-01
Target enrollment:
Participant gender:
Summary
The goal of this pilot clinical trial is to determine the effectiveness of Tirzepatide in
patients with persistent obesity (BMI > 30) 12 months after bariatric surgery (Roux-en-Y
Gastric Bypass). The investigators also aim to determine the frequency of side effects with
Tirzepatide in this patient population. Patients who take tirzepatide 12 months after
bariatric surgery will be compared to patients who receive a placebo.